09.11.25 -- Minimizing The Impact Of Human Errors Using Relational Risk Analysis

Examine the steps of cleaning validation for both low-volume and high-volume manufacturers and the important role these studies play.

Pharma leaders face rising pressure to deliver personalized therapies faster and more efficiently. Discover how top companies are evolving operations to stay agile, compliant, and competitive.

JHS partnered with a global pharma company to optimize biologic production, which increased output by 50% and reduced batch release times by up to 30%.

The pre-filled syringe space is one of the fastest-growing pharma sectors that offers greater patient safety. But pre-filled doesn’t translate to easily filled; there are particular obstacles to overcome.

Uncover an autoinjector technology that leverages laser-based headspace analysis for container closure integrity to advance biologic drug delivery with precision, safety, and regulatory confidence.

In the processing of ophthalmic solutions, high-shear mixers are utilized for dissolving salts as well as dispersing viscosity enhancers, antioxidants and other additives.

Next Generation Sequencing offers a sensitive, high-throughput solution for detecting adventitious viral agents to improve safety and accelerate regulatory-compliant product development.

Pre-use, post-sterilization integrity testing is vital for contamination control to ensure the integrity of sterilized equipment before use. Learn how PUPSIT can enhance safety and quality in your protocols.

Watch how payloads and advanced payload intermediates can expedite drug development and elevate ADC therapies, and explore ADC payloads, payload intermediates, and solubility-enhancing technology.

Find out how combining innovative technologies enables precise, individualized solid oral dosing—improving drug delivery, patient compliance, and therapeutic outcomes in applications.

A biotech with limited experience in the development and manufacture of high potency compounds sought to develop a process for producing a highly potent API used to treat an unmet oncology need.

Explore the challenges when moving a bioconjugate candidate from early development to clinic, along with integrated solutions for navigating this growing area of the biopharmaceutical industry.